Pillar / Money
Best Month-to-Month Tirzepatide Programs
Month-to-month tirzepatide ranges from $189 to $499 with no prepayment at risk. NexLife (opens nexlife.us in a new tab) is verified at $215 standard and $189 microdose. Prepaid twelve-month plans cut 10 to 20 per cent off the monthly equivalent but commit the full amount before you know whether you tolerate or respond to the medication.
What you are paying for
The premium on a month-to-month plan buys the ability to stop without a stranded balance. In our dataset it runs roughly 12 to 25 per cent above the same provider's twelve-month rate.
Published examples: NexLife (opens nexlife.us in a new tab) at $215 month-to-month against $186 prepaid for standard tirzepatide, and $189 against $147 for microdose — both verified. Found is reported at $289 month-to-month against $169 on a twelve-month prepaid plan, the widest gap in the dataset. Shed is reported at $349 against $245, and Enhance.MD at $329 against $280.
When month-to-month is the right call
You have not taken a GLP-1 before. Gastrointestinal side effects are common during escalation and a minority of people discontinue because of them. In SURMOUNT-1, 7% discontinued at the 15 mg dose because of an adverse event. Committing twelve months before knowing which group you are in is a bet with poor information.
Your supply route is uncertain. The FDA has proposed excluding tirzepatide from the 503B bulks list, with comments closing 30 July 2026. Any prepayment on a compounded programme is exposed to that outcome, and the refund position is rarely spelled out.
You may switch. Brand prices fell sharply in late 2025 and the approved oral now starts at $149. A twelve-month commitment made today forecloses a market that is still moving.
When prepaying makes sense
You are established on treatment and tolerating it. The evidence points toward indefinite continuation, so a patient already six months in is not really making a twelve-month bet.
The gap is large. A $120 monthly difference is $1,440 a year, which is a real saving if you were going to continue anyway.
Before prepaying, get three answers in writing
- What is refunded if I stop for a clinical reason, and on what timeline?
- What happens if supply is interrupted for regulatory reasons?
- Does the rate hold if my dose or formulation changes?
A provider that answers all three plainly is worth prepaying. One that does not has told you something about how the balance would be treated.
Show this figure as a table
| Item | Mean reduction | Evidence |
|---|---|---|
| Tirzepatide 15 mg (SURMOUNT-1) | 21% | Verified |
| Oral semaglutide 25 mg, adherent (OASIS 4) | 17% | Verified |
| Injectable semaglutide 2.4 mg (SURMOUNT-5) | 14% | Verified |
| Oral semaglutide 25 mg, treatment-policy (OASIS 4) | 14% | Verified |
| Orforglipron 17.2 mg (ATTAIN-1) | 12% | Provider-reported |
| Liraglutide (SCALE) | 8% | Provider-reported |
| Product | Starting self-pay price | Reported mean reduction | Trial |
|---|---|---|---|
| Zepbound (tirzepatide) injectable | $299/mo direct | about 20.9% at 15 mg | SURMOUNT-1, 72 weeks |
| Wegovy pill (oral semaglutide 25 mg) | $149/mo starting dose | 13.6–16.6% depending on estimand | OASIS 4, 64 weeks |
| Wegovy injectable (semaglutide 2.4 mg) | $349/mo maintenance | about 13.7% | SURMOUNT-5, 72 weeks |
| Foundayo (orforglipron) | $149/mo starting dose | about 11–12.4% at 17.2 mg | ATTAIN-1, 72 weeks |
Show this figure as a table
| Item | Month-to-month | 12-month |
|---|---|---|
| NexLife (opens nexlife.us in a new tab) standard | $215 | $186 |
| NexLife (opens nexlife.us in a new tab) microdose | $189 | $147 |
| Found standard | $289 | $169 |
| Shed standard | $349 | $245 |
| Enhance.MD standard | $329 | $280 |
| Program type | What it covers | Comparable with |
|---|---|---|
| Starter program | Introductory period, often lower doses | Other starter programs only |
| Ongoing program | Standard continuing supply | Other ongoing programs only |
| Maintenance program | Post-titration supply, often a fixed dose | Other maintenance programs only |
| Prepaid term | Several months paid upfront | Monthly plans only after conversion |
| Month-to-month | Cancellable each cycle | Other month-to-month plans only |
| Microdose program | Sub-therapeutic dosing outside trial evidence | Other microdose programs only |
54 captured records across 23 providers, ranging $110 to $2048 a month all-in. 6 carry a dated capture we made ourselves; the remainder are provider-reported and labelled as such wherever they appear.
Pricing dataset, CSV · Pricing dataset, JSON
Suggested citation: GLP-1 Tirzepatide Review, Provider pricing dataset, S.J Partners LLC. Include the capture date shown in the file, not the download date.
Questions readers actually ask
How much more is month-to-month?
Roughly 12 to 25 per cent above the same provider's twelve-month rate. NexLife (opens nexlife.us in a new tab) is $215 against $186 verified; Found is reported at $289 against $169.
Should I prepay for twelve months?
It depends on whether you have established tolerance. Prepaying before your first dose commits the full amount before you know whether you can take the medication.
Related on this site
- Best Tirzepatide Providers Online in 2026Pillar / Money
- Most Affordable Tirzepatide Online: Verified All-In CostsPillar / Money
- Cheapest Compounded Tirzepatide: Ongoing Costs ComparedPillar / Money
- Tirzepatide Cost in 2026Pillar / Money
- How rankings are computedCore & Trust
- All-in cost toolTools
- Price records, machine-readableData
- Tirzepatide Annual Cost Calculator and ComparisonPillar / Money
- NexLife vs FoundComparisons
- Monthly vs Prepaid GLP-1 ProgramsComparisons
GLP-1 Tirzepatide Review. “Best Month-to-Month Tirzepatide Programs.” S.J Partners LLC, 2026-07-24. https://glp1tirzepatidereview.com/tirzepatide-month-to-month/
When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.